Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-06 Lizzul Paul F. Chief Medical Officer Exercise or conversion +6,145 12,672
2024-01-06 Lizzul Paul F. Chief Medical Officer Exercise or conversion · Restricted Stock Unit −6,145 18,435
2024-01-06 LOUMEAU ERIC J Chief Legal Officer Exercise or conversion +5,545 5,545
2024-01-06 LOUMEAU ERIC J Chief Legal Officer Exercise or conversion · Restricted Stock Unit −5,545 16,635
2024-01-06 MULROY DENNIS Chief Financial Officer Exercise or conversion +5,245 6,209
2024-01-06 MULROY DENNIS Chief Financial Officer Exercise or conversion · Restricted Stock Unit −5,245 15,735
2024-01-06 Faga Daniel CEO Exercise or conversion +17,850 904,893
2024-01-06 Faga Daniel CEO Exercise or conversion · Restricted Stock Unit −17,850 53,550
2024-01-03 Jain Rita Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 Jain Rita Director Grant or award · Restricted Stock Unit +6,030 6,030
2024-01-03 Lizzul Paul F. Chief Medical Officer Grant or award · Stock Option (right to buy) +115,540 115,540
2024-01-03 Lizzul Paul F. Chief Medical Officer Grant or award · Restricted Stock Unit +42,220 42,220
2024-01-03 Marquet Magda Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 Marquet Magda Director Grant or award · Restricted Stock Unit +6,030 6,030
2024-01-03 Schmid John P. Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 Schmid John P. Director Grant or award · Restricted Stock Unit +6,030 6,030
2024-01-03 Orwin John A Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 Orwin John A Director Grant or award · Restricted Stock Unit +6,030 6,030
2024-01-03 RENTON HOLLINGS Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 RENTON HOLLINGS Director Grant or award · Restricted Stock Unit +6,030 6,030

Page 18 of 27 · 522 trades